115 related articles for article (PubMed ID: 34731766)
1. N-methylated diazabicyclo[3.2.2]nonane substituted triterpenoic acids are excellent, hyperbolic and selective inhibitors for butyrylcholinesterase.
Heise N; Friedrich S; Temml V; Schuster D; Siewert B; Csuk R
Eur J Med Chem; 2022 Jan; 227():113947. PubMed ID: 34731766
[TBL] [Abstract][Full Text] [Related]
2. Triterpene-Based Carboxamides Act as Good Inhibitors of Butyrylcholinesterase.
Loesche A; Kahnt M; Serbian I; Brandt W; Csuk R
Molecules; 2019 Mar; 24(5):. PubMed ID: 30866589
[TBL] [Abstract][Full Text] [Related]
3. Oxidation at C-16 enhances butyrylcholinesterase inhibition in lupane triterpenoids.
Castro MJ; Richmond V; Faraoni MB; Murray AP
Bioorg Chem; 2018 Sep; 79():301-309. PubMed ID: 29793143
[TBL] [Abstract][Full Text] [Related]
4. Amino derivatives of platanic acid act as selective and potent inhibitors of butyrylcholinesterase.
Heller L; Kahnt M; Loesche A; Grabandt P; Schwarz S; Brandt W; Csuk R
Eur J Med Chem; 2017 Jan; 126():652-668. PubMed ID: 27936444
[TBL] [Abstract][Full Text] [Related]
5. Preparation, anticholinesterase activity and molecular docking of new lupane derivatives.
Castro MJ; Richmond V; Romero C; Maier MS; Estévez-Braun A; Ravelo AG; Faraoni MB; Murray AP
Bioorg Med Chem; 2014 Jul; 22(13):3341-50. PubMed ID: 24835788
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and cholinesterase inhibiting potential of A-ring azepano- and 3-amino-3,4-seco-triterpenoids.
Kazakova O; Smirnova I; Lopatina T; Giniyatullina G; Petrova A; Khusnutdinova E; Csuk R; Serbian I; Loesche A
Bioorg Chem; 2020 Aug; 101():104001. PubMed ID: 32683137
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of novel carbamates as potential inhibitors of acetylcholinesterase and butyrylcholinesterase.
Wu J; Pistolozzi M; Liu S; Tan W
Bioorg Med Chem; 2020 Mar; 28(5):115324. PubMed ID: 32008882
[TBL] [Abstract][Full Text] [Related]
8. Ursolic and oleanolic acid derivatives with cholinesterase inhibiting potential.
Loesche A; Köwitsch A; Lucas SD; Al-Halabi Z; Sippl W; Al-Harrasi A; Csuk R
Bioorg Chem; 2019 Apr; 85():23-32. PubMed ID: 30599410
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(substituted/-nonsubstituted benzal)hydrazone derivatives and acetylcholinesterase and butyrylcholinesterase inhibitory activities in vitro.
Utku S; Gökçe M; Orhan I; Sahin MF
Arzneimittelforschung; 2011; 61(1):1-7. PubMed ID: 21355440
[TBL] [Abstract][Full Text] [Related]
10. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
Mutahir S; Jończyk J; Bajda M; Khan IU; Khan MA; Ullah N; Ashraf M; Qurat-ul-Ain ; Riaz S; Hussain S; Yar M
Bioorg Chem; 2016 Feb; 64():13-20. PubMed ID: 26595185
[TBL] [Abstract][Full Text] [Related]
11. Converting maslinic acid into an effective inhibitor of acylcholinesterases.
Schwarz S; Loesche A; Lucas SD; Sommerwerk S; Serbian I; Siewert B; Pianowski E; Csuk R
Eur J Med Chem; 2015 Oct; 103():438-45. PubMed ID: 26383128
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro evaluation of novel rhodanine derivatives as potential cholinesterase inhibitors.
Krátký M; Štěpánková Š; Vorčáková K; Vinšová J
Bioorg Chem; 2016 Oct; 68():23-9. PubMed ID: 27428597
[TBL] [Abstract][Full Text] [Related]
13. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
Makhaeva GF; Lushchekina SV; Boltneva NP; Serebryakova OG; Rudakova EV; Ustyugov AA; Bachurin SO; Shchepochkin AV; Chupakhin ON; Charushin VN; Richardson RJ
Bioorg Med Chem; 2017 Nov; 25(21):5981-5994. PubMed ID: 28986116
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and evaluation of difunctionalized 4-hydroxybenzaldehyde derivatives as novel cholinesterase inhibitors.
Yu L; Cao R; Yi W; Yan Q; Chen Z; Ma L; Song H
Chem Pharm Bull (Tokyo); 2010 Sep; 58(9):1216-20. PubMed ID: 20823602
[TBL] [Abstract][Full Text] [Related]
15. Alkynyl and β-ketophosphonates: Selective and potent butyrylcholinesterase inhibitors.
Cavallaro V; Moglie YF; Murray AP; Radivoy GE
Bioorg Chem; 2018 Apr; 77():420-428. PubMed ID: 29427857
[TBL] [Abstract][Full Text] [Related]
16. Ionic liquid-enabled synthesis, cholinesterase inhibitory activity, and molecular docking study of highly functionalized tetrasubstituted pyrrolidines.
Kumar RS; Almansour AI; Arumugam N; Althomili DMQ; Altaf M; Basiri A; D K; Sai Manohar T; S V
Bioorg Chem; 2018 Apr; 77():263-268. PubMed ID: 29421701
[TBL] [Abstract][Full Text] [Related]
17. New potent acetylcholinesterase inhibitors in the tetracyclic triterpene series.
Sauvaître T; Barlier M; Herlem D; Gresh N; Chiaroni A; Guenard D; Guillou C
J Med Chem; 2007 Nov; 50(22):5311-23. PubMed ID: 17902635
[TBL] [Abstract][Full Text] [Related]
18. Cyclic acyl guanidines bearing carbamate moieties allow potent and dirigible cholinesterase inhibition of either acetyl- or butyrylcholinesterase.
Darras FH; Kling B; Sawatzky E; Heilmann J; Decker M
Bioorg Med Chem; 2014 Sep; 22(17):5020-34. PubMed ID: 25059502
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of novel coumarin-pyridinium hybrids: In vitro cholinesterase inhibitory activity.
Vafadarnejad F; Mahdavi M; Karimpour-Razkenari E; Edraki N; Sameem B; Khanavi M; Saeedi M; Akbarzadeh T
Bioorg Chem; 2018 Apr; 77():311-319. PubMed ID: 29421707
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel 5-(aroylhydrazinocarbonyl)escitalopram as cholinesterase inhibitors.
Nisa MU; Munawar MA; Iqbal A; Ahmed A; Ashraf M; Gardener QA; Khan MA
Eur J Med Chem; 2017 Sep; 138():396-406. PubMed ID: 28688279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]